Copyright: ©Author(s) 2026.
World J Hepatol. Aug 27, 2026; 18(8): 124474
Published online Aug 27, 2026. doi: 10.4254/wjh.124474
Published online Aug 27, 2026. doi: 10.4254/wjh.124474
Table 4 Exploratory age-male-albumin-bilirubin-platelet score strata for hepatocellular carcinoma risk
| Risk of developing de novo HCC | aMAP | Annual HCC incidence % (95%CI) | Proportion of the cohort, % |
| Low | < 55 | 0.0 | 18.55 |
| Intermediate | 55 to < 60 | 2.42 (1.21-4.84) | 22.96 |
| High | ≥ 60 | 6.42 (4.81-8.57) | 58.49 |
- Citation: Khongviwatsathien S, Tanwandee T. Age-male-albumin-bilirubin-platelet score stratifies hepatocellular carcinoma risk after sustained virological response in hepatitis C-related compensated advanced chronic liver disease. World J Hepatol 2026; 18(8): 124474
- URL: https://www.wjgnet.com/1948-5182/full/v18/i8/124474.htm
- DOI: https://dx.doi.org/10.4254/wjh.124474